2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Top Cited Papers
Open Access
- 25 September 2018
- journal article
- review article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 24 (3), 169-229
- https://doi.org/10.3350/cmh.2018.1004
Abstract
No abstract availableKeywords
This publication has 219 references indexed in Scilit:
- Trends of Mortality and Cause of Death among HIV-Infected Patients in Korea, 1990-2011Journal of Korean Medical Science, 2013
- Causes of Death and Risk Factors for Mortality among HIV-Infected Patients Receiving Antiretroviral Therapy in KoreaJournal of Korean Medical Science, 2013
- Management of hepatitis C in HIV and/or HBV co-infected patientsBest Practice & Research Clinical Gastroenterology, 2012
- Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational StudyGut and Liver, 2012
- The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis CGastroenterology, 2011
- Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virusClinical and Molecular Hepatology, 2011
- Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell CountsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virusHepatology, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adultsAIDS, 2007